Aurobindo Pharma to divest Natrol to New Mountain Capital

Aurobindo Pharma to divest Natrol to New Mountain Capital

by admin- Monday, October 26th, 2020 04:25:16 PM

Aurobindo Pharma has reached a definitive agreement to sell Natrol LLC., an entirely owned subsidiary of Aurobindo Pharma USA, Inc., to an associate of New Mountain
Capital to combine with Jarrow Formulas.

The all-coins transaction is worth USD 550 Million (or Rs. Four,048 Cr at the modern-day alternate charge). Subject to standard ultimate situations and regulatory approvals, the transaction is predicted to close through January 2021.

Natrol’s annual sales for the twelve months ended March 31, 2020 become approximately USD 157 Million.

News Updates